Citius Oncology, Inc. · NASDAQ:CTOR
Citius Pharmaceuticals, Inc. reported a 71.00% stake in Citius Oncology, Inc. (Schedule 13D/A)
Event May 15, 2026 · Filed Jun 4, 2026
Citius Pharmaceuticals, Inc. reported a 71.00% stake in Citius Oncology, Inc., 66,049,615 shares, with active intent on May 15, 2026. Filed Jun 4, 2026 (Schedule 13D/A).
- Stake
- 71.00%
- Shares
- 66,049,615
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citius Pharmaceuticals, Inc. | 71.00% | 66,049,615 |
Source
Related
- Citius Oncology, Inc.
- Citius Pharmaceuticals, Inc.
- Citius Oncology, Inc. shareholders
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Dec 17, 2025
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Sep 12, 2025
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Jul 25, 2025
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G · Armistice Capital, LLC · Nov 14, 2025